Jupiter Neurosciences, Inc. Common Stock (JUNS) — Financial Flexibility Index
Jupiter Neurosciences, Inc. Common Stock (JUNS) has a Financial Flexibility Index of -0.56x as of June 2026. Free cash flow of $-2.29 Million (operating CF $-2.29 Million minus capex $0.00) represents -1% of total liabilities ($4.08 Million). Check Jupiter Neurosciences, Inc. Common Stock (JUNS) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Jupiter Neurosciences, Inc. Common Stock Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for Jupiter Neurosciences, Inc. Common Stock across 7 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Jupiter Neurosciences, Inc. Common Stock.
Annual Financial Flexibility Index for Jupiter Neurosciences, Inc. Common Stock (2019–2025)
Year-by-year free cash flow to debt coverage for Jupiter Neurosciences, Inc. Common Stock. Explore JUNS operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.73x | $-5.41 Million | $-5.41 Million | $7.40 Million | ▲ +62.0% |
| 2024 | -1.93x | $-3.91 Million | $-3.91 Million | $2.03 Million | ▼ -2283.0% |
| 2023 | -0.08x | $-480.95K | $-480.95K | $5.95 Million | ▲ +52.2% |
| 2022 | -0.17x | $-1.25 Million | $-1.25 Million | $7.38 Million | ▲ +43.0% |
| 2021 | -0.30x | $-1.74 Million | $-1.74 Million | $5.85 Million | ▼ -396.4% |
| 2020 | -0.06x | $-254.78K | $-254.78K | $4.26 Million | ▼ -110.1% |
| 2019 | -0.03x | $-142.95K | $-142.95K | $5.02 Million | — |